FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Gimenez, IL
   Arakaki, VDNM
   Correa, RM
   dos Santos, RS
   Peres, RT
   Sant'Anna, CC
   Ferreira, HC
AF Gimenez, Isabelle Leandro
   Neves Moreira Arakaki, Vanessa da Silva
   Correa, Raquel Miranda
   dos Santos, Rosana Silva
   Peres, Rodrigo Tosta
   Sant'Anna, Clemax Couto
   Ferreira, Halina Cidrini
TI Neonatal pain: characterization of the physiotherapist's perception in
   the Neonatal Intensive Care Unit
SO REVISTA PAULISTA DE PEDIATRIA
LA Portuguese
DT Article
DE Pain; Pain measurement; infant premature; physiotherapy; neonatal
   intensive care unit
ID DEFINITION; NICU
AB Objective: To describe the perception of physiotherapists in neonatal units regarding pain, the use of measurement scales and strategies that minimize pain.
   Methods: Interviews were conducted with physiotherapists in hospitals with neonatal units between 2013 and 2015 in Rio de Janeiro. The questions concerned the knowledge of the feeling of pain, from its recognition to its care or treatment. The description of the results was done by comparing public and private hospitals (Fisher"s Exact exact Testtest), considering p<0.05 as significant.
   Results: 27 hospitals were visited. All the professionals interviewed (n=27) stated that the newborns feel pain, with facial expression being the most cited and known sign for pain. 26% of physiotherapists believe that newborns experience pain at the same magnitude as adults. Among the scales, the Neonatal Infant Pain Scale (NIPS) was the most well known, but only 37% of the units had routine pain assessment protocols. IV cannulation and blood collection were the most mentioned procedures as a cause of pain and there was no difference between public and private hospitals.
   Conclusions: There is a gap in the knowledge about neonatal pain and how to evaluate it among the participating physiotherapists, with no systematization of care routines involving this assessment.
C1 [Gimenez, Isabelle Leandro; Neves Moreira Arakaki, Vanessa da Silva; Correa, Raquel Miranda; dos Santos, Rosana Silva; Sant'Anna, Clemax Couto; Ferreira, Halina Cidrini] Univ Fed Rio de Janeiro, Rio De Janeiro, RJ, Brazil.
   [Peres, Rodrigo Tosta] Ctr Fed Educ Tecnol Celso Suckow Fonseca Rio de J, Rio De Janeiro, RJ, Brazil.
RP Ferreira, HC (corresponding author), Univ Fed Rio de Janeiro, Rio De Janeiro, RJ, Brazil.
EM halinacidrini@me.ufrj.br
OI Ferreira, Halina Cidrini/0000-0002-0111-5649
CR Alves FB, 2013, REV CUID, V4, P510
   Anand KJS, 1996, PAIN, V67, P3
   Arakaki Vanessa da Silva Neves Moreira, 2017, Fisioter. Pesqui., V24, P143, DOI 10.1590/1809-2950/16470124022017
   Balda RCX, 2018, LINGUAGEM DOR RECEMN
   Batalha L, 2005, ACTA PEDIAT PORT, V36, P201
   Bueno M, 2007, SINAL VITAL REFLEXOE, P228
   Capellini VK, 2014, REV ELETR ENF, V16, P361
   Carter BS, 2017, SEMIN PERINATOL, V41, P111, DOI 10.1053/j.semperi.2016.11.001
   Christoffel MM, 2002, ESC ANNA NERY, V6, P53
   Cruz Cibele Thomé da, 2016, Rev. dor, V17, P197, DOI 10.5935/1806-0013.20160070
   de Aymar CLG, 2014, J PEDIAT-BRAZIL, V90, P308, DOI 10.1016/j.jped.2013.09.008
   Melo Gleicia Martins de, 2014, Rev. paul. pediatr., V32, P395, DOI [10.1590/S0103-05822014000400017, 10.1016/j.rpped.2014.04.007]
   Derbyshire SWG, 2006, BRIT MED J, V332, P909, DOI 10.1136/bmj.332.7546.909
   Falcao LFM, 2007, REV PAUL PEDIATR, V25, P53
   Keels E, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-4271
   Lanza Fernanda de Cordoba, 2010, Rev. paul. pediatr., V28, P10, DOI 10.1590/S0103-05822010000100003
   Linhares MBM, 2012, DESENVOLVIMENTO CRIA, P56
   Lohmann PM, 2017, REV DESTAQUES ACAD, V9, P34, DOI [10.22410/issn.2176-3070.v9i3a2017.1328, DOI 10.22410/ISSN.2176-3070.V9I3A2017.1328]
   Maxwell LG, 2013, CLIN PERINATOL, V40, P457, DOI 10.1016/j.clp.2013.05.001
   Motta BTS, 2017, INT ARCH MED, V10, P1
   Moura- Ribeiro MV, 2010, NEUROLOGIA DESENVOLV
   Polkki T, 2010, SCAND J CARING SCI, V24, P49, DOI 10.1111/j.1471-6712.2008.00683.x
   Prestes Ana Claudia Y., 2005, J. Pediatr. (Rio J.), V81, P405, DOI 10.1590/S0021-75572005000600012
   Santos LM, 2012, REV BRAS ENFERM, V65, P27, DOI 10.1590/S0034-71672012000100004
   Silva Y, 2006, DOR PEDIATRIA
   Soares AC, 2016, COGITARE ENFERM, V21, P1
   Vinall J, 2012, PAIN, V153, P1374, DOI 10.1016/j.pain.2012.02.007
   Williams ACD, 2016, PAIN, V157, P2420, DOI 10.1097/j.pain.0000000000000613
   Prestes ACY, 2016, J PEDIAT-BRAZIL, V92, P88, DOI 10.1016/j.jped.2015.04.009
   2006, PEDIATRICS, V118, P2231, DOI DOI 10.1542/PEDS.2006-2277
NR 30
TC 0
Z9 0
U1 0
U2 0
PU SOC PEDIATRIA SAO PAULO
PI SAO PAULO SP
PA ALAMEDA SANTOS 211, 5O ANDAR, SAO PAULO SP, 01419-000, BRAZIL
SN 0103-0582
EI 1984-0462
J9 REV PAUL PEDIATR
JI Rev. Paul. Pediatr.
PY 2020
VL 38
AR e2018178
DI 10.1590/1984-0462/2020/38/2018178
PG 6
WC Pediatrics
SC Pediatrics
GA NO0KK
UT WOS:000569176000066
PM 31778412
OA DOAJ Gold, Green Published
DA 2020-10-30
ER

PT J
AU Cardoso, TF
   dos Santos, RS
   Correa, RM
   Campos, JV
   Silva, RD
   Tobias, CC
   Prata-Barbosa, A
   da Cunha, AJLA
   Ferreira, HC
AF Cardoso, Taissa Ferreira
   dos Santos, Rosana Silva
   Correa, Raquel Miranda
   Campos, Juliana Vieira
   Silva, Ricardo de Bastos
   Tobias, Christine Castinheiras
   Prata-Barbosa, Arnaldo
   Ledo Alves da Cunha, Antonio Jose
   Ferreira, Halina Cidrini
TI Congenital Zika infection: neurology can occur without microcephaly
SO ARCHIVES OF DISEASE IN CHILDHOOD
LA English
DT Letter
C1 [Cardoso, Taissa Ferreira; Campos, Juliana Vieira] Univ Fed Rio de Janeiro, Maternidade Escola, Postgrad Program Perinatal Hlth Care, Rio de Janeiro, Brazil.
   [dos Santos, Rosana Silva; Ferreira, Halina Cidrini] Univ Fed Rio de Janeiro, Sch Med, Dept Phys Therapy, BR-21941913 Rio de Janeiro, RJ, Brazil.
   [dos Santos, Rosana Silva; Ferreira, Halina Cidrini] Univ Fed Rio de Janeiro, Maternidade Escola, Program Perinatal Hlth Care, Rio de Janeiro, Brazil.
   [Correa, Raquel Miranda; Tobias, Christine Castinheiras] Univ Fed Rio de Janeiro, Maternidade Escola, Rio de Janeiro, Brazil.
   [Silva, Ricardo de Bastos] Univ Fed Rio de Janeiro, Sch Med, Phys Therapy Course, Rio de Janeiro, Brazil.
   [Prata-Barbosa, Arnaldo; Ledo Alves da Cunha, Antonio Jose] Univ Fed Rio de Janeiro, Sch Med, Dept Pediat, Rio de Janeiro, Brazil.
   [Prata-Barbosa, Arnaldo; Ledo Alves da Cunha, Antonio Jose] DOr Inst Res & Educ IDOR, Rio De Janeiro, Brazil.
RP Ferreira, HC (corresponding author), Univ Fed Rio de Janeiro, Sch Med, Dept Phys Therapy, BR-21941913 Rio de Janeiro, RJ, Brazil.
EM halinacidrini@me.ufrj.br
RI da Cunha, Antonio Jose Ledo Alves/O-5914-2019; Prata-Barbosa,
   Arnaldo/B-2212-2009
OI da Cunha, Antonio Jose Ledo Alves/0000-0003-3592-1849; Prata-Barbosa,
   Arnaldo/0000-0002-4726-9782; Ferreira, Halina
   Cidrini/0000-0002-0111-5649
CR [Anonymous], 2016, BMJ, V353, pi3182, DOI 10.1136/bmj.i3182
   Marinho Penelope Saldanha, 2017, Matern Health Neonatol Perinatol, V3, P17, DOI 10.1186/s40748-017-0054-0
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   World Health Organization, CHILD GROWTH STAND H
   Yang H, 2012, EARLY HUM DEV, V88, P837, DOI 10.1016/j.earlhumdev.2012.06.004
NR 5
TC 7
Z9 8
U1 0
U2 6
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0003-9888
EI 1468-2044
J9 ARCH DIS CHILD
JI Arch. Dis. Child.
PD FEB
PY 2019
VL 104
IS 2
BP 199
EP +
DI 10.1136/archdischild-2018-314782
PG 2
WC Pediatrics
SC Pediatrics
GA HM7DY
UT WOS:000459638700028
PM 29858269
DA 2020-10-30
ER

PT J
AU Ferreira, HC
   Mazzoli-Rocha, F
   Momesso, DP
   Garcia, CSNB
   Carvalho, GMC
   Lassance-Soares, RM
   Prota, LFM
   Morales, MM
   Faffe, DS
   Carvalho, AR
   Rocco, PRM
   Zin, WA
AF Ferreira, Halina C.
   Mazzoli-Rocha, Flavia
   Momesso, Denise P.
   Garcia, Cristiane S. N. B.
   Carvalho, Giovanna M. C.
   Lassance-Soares, Roberta M.
   Prota, Luiz F. M.
   Morales, Marcelo M.
   Faffe, Debora S.
   Carvalho, Alysson R.
   Rocco, Patricia R. M.
   Zin, Walter A.
TI On the crucial ventilatory setting adjustment from two- to one-lung
   ventilation
SO RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY
LA English
DT Article
DE One-lung ventilation; Procollagen type-III; Shear stress; VILI;
   Extracellular matrix expression; Protective ventilator strategies
ID END-EXPIRATORY PRESSURE; VOLUME-CONTROLLED VENTILATION;
   THORACIC-SURGERY; TIDAL VOLUME; MECHANICAL VENTILATION; RESPIRATORY
   MECHANICS; EXTRACELLULAR-MATRIX; AIRWAY PRESSURES; GAS-EXCHANGE; RAT
   LUNGS
AB Lung mechanics, histology, oxygenation and type-III procollagen (PCIII) mRNA were studied aiming to evaluate the need to readjust ventilatory pattern when going from two- to one-lung ventilation (OLV). Wistar rats were assigned to three groups: the left lung was not ventilated while the right lung received: (1) tidal volume (V-T) = 5 ml/kg and positive end-expiratory pressure (PEEP)= 2 cm H2O (V5P2), (2) V-T = 10 ml/kg and PEEP = 2 cm H2O (V10P2), and (3) V-T = 5 ml/kg and PEEP = 5 cm H2O (V5P5). At 1-h ventilation, V5P2 showed hypoxemia, alveolar collapse and impaired lung function. Higher PEEP minimized these changes and prevented hypoxemia. Although high V-T prevented hypoxemia and maintained a higher specific compliance than V5P2, a morphologically inhomogeneous parenchyma and higher PCIII expression resulted. In conclusion, the association of low V-T and an adequate PEEP level could be useful to maintain arterial oxygenation without inducing a possible inflammatory/remodeling response. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Zin, Walter A.] Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Biofis Carlos Chagas Filho, Lab Fisiol Resp,Ilha Fundao, BR-21941902 Rio De Janeiro, Brazil.
   [Garcia, Cristiane S. N. B.; Rocco, Patricia R. M.] Univ Fed Rio de Janeiro, Lab Pulm Invest, Inst Biofis Carlos Chagas Filho, BR-21941902 Rio De Janeiro, Brazil.
   [Lassance-Soares, Roberta M.; Prota, Luiz F. M.; Morales, Marcelo M.] Univ Fed Rio de Janeiro, Lab Cellular & Mol Physiol, Inst Biofis Carlos Chagas Filho, BR-21941902 Rio De Janeiro, Brazil.
RP Zin, WA (corresponding author), Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Biofis Carlos Chagas Filho, Lab Fisiol Resp,Ilha Fundao, BR-21941902 Rio De Janeiro, Brazil.
EM hcidrini@gmail.com; flamazzoli@gmail.com; dmomesso@terra.com.br;
   crisbaezgarcia@gmail.com; giovannamcc@gmail.com;
   ro.lassance@yahoo.com.br; felprota@gmail.com; mmorales@biof.ufrj.br;
   faffe@biof.ufrj.br; roncally.carvalho@gmail.com; prmrocco@biof.ufrj.br;
   walter_zin@hotmail.com
RI Carvalho, Alysson/AAF-1022-2019; Zin, Walter/H-8220-2013; Fisiologia,
   Ciencias Biologicas/C-2407-2012
OI Zin, Walter/0000-0001-8226-9123; Mazzoli da Rocha,
   Flavia/0000-0003-0972-194X; Carvalho, Alysson/0000-0003-2708-7735
FU PRONEX-FAPERJCarlos Chagas Filho Foundation for Research Support of the
   State of Rio de Janeiro (FAPERJ); Brazilian Council for Scientific and
   Technological Development (CNPq/MCT)National Council for Scientific and
   Technological Development (CNPq); Carlos Chagas Filho Rio de Janeiro
   State Research Supporting Foundation (FAPERJ)Carlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
FX This work was supported by The Centers of Excellence Program
   (PRONEX-FAPERJ), The Brazilian Council for Scientific and Technological
   Development (CNPq/MCT), and The Carlos Chagas Filho Rio de Janeiro State
   Research Supporting Foundation (FAPERJ).
CR Asaph JW, 2000, ANN THORAC SURG, V70, P373, DOI 10.1016/S0003-4975(00)01364-3
   BATES JHT, 1985, J APPL PHYSIOL, V58, P1840
   Brodsky JB, 2001, WORLD J SURG, V25, P162
   Unzueta MC, 2007, ANESTH ANALG, V104, P1029, DOI 10.1213/01.ane.0000260313.63893.2f
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Copland IB, 2003, AM J RESP CRIT CARE, V168, P1051, DOI 10.1164/rccm.200208-964OC
   Pardos PC, 2009, J CARDIOTHOR VASC AN, V23, P770, DOI 10.1053/j.jvca.2009.06.002
   D'Angelo E, 2002, J APPL PHYSIOL, V92, P949, DOI 10.1152/japplphysiol.00776.2001
   de Abreu MG, 2003, ANESTH ANALG, V96, P220, DOI 10.1213/01.ANE.0000040081.52397.34
   de Carvalho MEP, 2007, CRIT CARE, V11, DOI 10.1186/cc5702
   de Prost N, 2007, INTENS CARE MED, V33, P711, DOI 10.1007/s00134-007-0575-5
   Dreyfuss D, 1998, AM J RESP CRIT CARE, V157, P294, DOI 10.1164/ajrccm.157.1.9604014
   Farias LL, 2005, J APPL PHYSIOL, V98, P53, DOI 10.1152/japplphysiol.00118.2004
   Frank JA, 2002, AM J RESP CRIT CARE, V165, P242, DOI 10.1164/ajrccm.165.2.2108087
   Gal TJ, 2006, ANESTH ANALG, V103, P271, DOI 10.1213/01.ane.0000223678.64129.7c
   Garcia CSNB, 2004, RESP PHYSIOL NEUROBI, V144, P59, DOI 10.1016/j.resp.2004.07.023
   Gattinoni L, 2003, EUR RESPIR J, V22, p15S, DOI 10.1183/09031936.03.00021303
   GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x
   Ishikawa S, 2011, CURR OPIN ANESTHESIO, V24, P24, DOI 10.1097/ACO.0b013e3283415659
   Kilpatrick B, 2010, BRIT J ANAESTH, V105, pI108, DOI 10.1093/bja/aeq299
   KOCHI T, 1988, J APPL PHYSIOL, V64, P441
   Lohser Jens, 2008, Anesthesiol Clin, V26, P241, DOI 10.1016/j.anclin.2008.01.011
   MEAD J, 1959, J APPL PHYSIOL, V14, P669
   Michelet P, 2005, BRIT J ANAESTH, V95, P267, DOI 10.1093/bja/aei178
   Michelet P, 2006, ANESTHESIOLOGY, V105, P911, DOI 10.1097/00000542-200611000-00011
   Montes FR, 2010, J CARDIOTHORAC SURG, V5, DOI 10.1186/1749-8090-5-99
   Musch G, 2007, ANESTHESIOLOGY, V106, P723, DOI 10.1097/01.anes.0000264748.86145.ac
   Nagase T, 1996, J APPL PHYSIOL, V80, P583
   Parker JC, 1997, J APPL PHYSIOL, V83, P1697
   Prella M, 2002, CHEST, V122, P1382, DOI 10.1378/chest.122.4.1382
   RAGHU G, 1985, AM REV RESPIR DIS, V131, P281, DOI 10.1164/ajrccm/138.3.703
   Rocco PRM, 2001, AM J RESP CRIT CARE, V164, P1067, DOI 10.1164/ajrccm.164.6.2007062
   SALDIVA PHN, 1992, J APPL PHYSIOL, V72, P302
   SCHERLE W, 1970, Mikroskopie, V26, P57
   Schilling T, 2005, ANESTH ANALG, V101, P957, DOI 10.1213/01.ane.0000172112.02902.77
   SIMILOWSKI T, 1989, J APPL PHYSIOL, V67, P2219
   SUTER PM, 1978, CHEST, V73, P158, DOI 10.1378/chest.73.2.158
   Tekinbas C, 2007, J THORAC CARDIOV SUR, V134, P405, DOI 10.1016/j.jtcvs.2007.05.003
   Tugrul M, 1997, BRIT J ANAESTH, V79, P306, DOI 10.1093/bja/79.3.306
   Watanabe S, 2000, ANESTH ANALG, V90, P28, DOI 10.1097/00000539-200001000-00007
   Weibel E.R., 1990, MODELS LUNG DIS MICR, V47, P199
NR 41
TC 5
Z9 7
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1569-9048
EI 1878-1519
J9 RESP PHYSIOL NEUROBI
JI Respir. Physiol. Neuro.
PD DEC 15
PY 2011
VL 179
IS 2-3
BP 198
EP 204
DI 10.1016/j.resp.2011.08.006
PG 7
WC Physiology; Respiratory System
SC Physiology; Respiratory System
GA 859VI
UT WOS:000297903500018
PM 21871975
DA 2020-10-30
ER

PT J
AU Burburan, SM
   Xisto, DG
   Ferreira, HC
   Riva, DD
   Carvalho, GMC
   Zin, WA
   Rocco, PRM
AF Burburan, Shirley Moreira
   Xisto, Debora Goncalves
   Ferreira, Halina Cidrini
   dos Reis Riva, Douglas
   Cavalcante Carvalho, Giovanna Marcella
   Zin, Walter Araujo
   Macedo Rocco, Patricia Rieken
TI Lung mechanics and histology during sevoflurane anesthesia in a model of
   chronic allergic asthma
SO ANESTHESIA AND ANALGESIA
LA English
DT Article
ID RESPIRATORY MECHANICS; TRACHEAL INTUBATION; SMOOTH-MUSCLE;
   PEDIATRIC-PATIENTS; MURINE MODEL; MOUSE MODEL; AIRWAY; INFLAMMATION;
   PREVALENCE; ISOFLURANE
AB BACKGROUND: There are no studies examining the effects of sevoflurane on a chronically inflamed and remodeled airway, such as that found in asthma. In the present study, we sought to define the respiratory effects of sevoflurane in a model of chronic allergic asthma. For this purpose, pulmonary mechanics were studied and lung morphometry analyzed to determine whether the physiological modifications reflected underlying morphological changes.
   METHODS: Thirty-six BALB/c mice (20-25 g) were randomly divided into four groups. In OVA groups, mice were sensitized with ovalbumin and exposed to repeated ovalbumin challenges. In SAL groups, mice received saline using the same protocol. Twenty-four hours after the last challenge, the animals were anesthetized with pentobarbital sodium (PENTO, 20 mg/kg i.p.) or sevoflurane (SEVO, 1 MAC). Lung static elastance (E-st), resistive (Delta P-1) and viscoelastic/inhomogeneous (Delta P-2) pressure decreases were analyzed by an end-inflation occlusion method. Lungs were fixed and stained for histological analysis.
   RESULTS: Animals in the OVASEVO group showed lower Delta P-1 (38%), Delta P-2 (24%), and E-st (22%) than animals in the OVAPENTO group. Histology demonstrated greater airway dilation (16%) and a lower degree of alveolar collapse (25%) in the OVASEVO compared with OVAPENTO group. Delta P-1 was lower (35%) and airway diameters larger (12%) in the SALSEVO compared with SALPENTO group.
   CONCLUSION: Sevoflurane anesthesia acted both at airway level and lung periphery reducing (Delta P-1 and Delta P-2 pressures, and E-st in chronic allergic asthma.
C1 Univ Fed Rio de Janeiro, Lab Invest Pulm, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Fac Med, Div Anesthesiol, BR-21941 Rio De Janeiro, Brazil.
RP Rocco, PRM (corresponding author), Univ Fed Rio de Janeiro, Lab Invest Pulm, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil.
EM prmrocco@biof.ufrj.br
RI Zin, Walter/H-8220-2013
OI Zin, Walter/0000-0001-8226-9123
CR Arif AA, 2004, J PAEDIATR CHILD H, V40, P189, DOI 10.1111/j.1440-1754.2004.00335.x
   Barnes PJ, 1996, AM J RESP CRIT CARE, V153, pS5, DOI 10.1164/ajrccm/153.6_Pt_2.S5
   BATES JHT, 1988, J APPL PHYSIOL, V64, P2204
   Beasley R, 2000, J ALLERGY CLIN IMMUN, V105, pS466, DOI 10.1016/S0091-6749(00)90044-7
   Blyth DI, 1996, AM J RESP CELL MOL, V14, P425, DOI 10.1165/ajrcmb.14.5.8624247
   Bousquet J, 2000, AM J RESP CRIT CARE, V161, P1720, DOI 10.1164/ajrccm.161.5.9903102
   BROWN B, 1995, ANESTH ANALG, V81, pS1, DOI 10.1097/00000539-199512001-00001
   Cerveri I, 1999, EUR RESPIR J, V14, P288, DOI 10.1034/j.1399-3003.1999.14b09.x
   Cohn L, 2004, ANNU REV IMMUNOL, V22, P789, DOI 10.1146/annurev.immunol.22.012703.104716
   Correa FCF, 2001, J APPL PHYSIOL, V91, P803
   FLETCHER SW, 1968, ANESTHESIOLOGY, V29, P517, DOI 10.1097/00000542-196805000-00027
   Goff MJ, 2000, ANESTHESIOLOGY, V93, P404, DOI 10.1097/00000542-200008000-00018
   Gomes RFM, 2000, J APPL PHYSIOL, V89, P908
   Gomes RFM, 2002, RESP PHYSIOL NEUROBI, V130, P317, DOI 10.1016/S0034-5687(02)00017-8
   Groeben H, 2004, Best Pract Res Clin Anaesthesiol, V18, P579, DOI 10.1016/j.bpa.2004.05.013
   Habre W, 1999, ANESTH ANALG, V89, P1177, DOI 10.1213/00000539-199911000-00017
   INOMATA S, 1994, ANESTHESIOLOGY, V80, P93, DOI 10.1097/00000542-199401000-00016
   Ishikawa T, 1998, BRIT J ANAESTH, V80, P807, DOI 10.1093/bja/80.6.807
   JAMES AL, 1988, AM REV RESPIR DIS, V138, P136, DOI 10.1164/ajrccm/138.1.136
   KATOH T, 1994, CAN J ANAESTH, V41, P1214, DOI 10.1007/BF03020665
   Kips JC, 2003, EUR RESPIR J, V22, P374, DOI 10.1183/09031936.03.00026403
   Mazzeo AT, 2004, PEDIATR ANESTH, V14, P596, DOI 10.1111/j.1460-9592.2004.01260.x
   MITSUHATA H, 1994, ANESTHESIOLOGY, V81, P1230, DOI 10.1097/00000542-199411000-00017
   Park KW, 1998, ANESTH ANALG, V86, P646, DOI 10.1097/00000539-199803000-00039
   Que JC, 1999, ANESTHESIOLOGY, V90, P1475, DOI 10.1097/00000542-199905000-00033
   Rhodes L, 2003, JAMA-J AM MED ASSOC, V289, P2639
   Rooke GA, 1997, ANESTHESIOLOGY, V86, P1294, DOI 10.1097/00000542-199706000-00010
   SAKAE RS, 1994, AM J PHYSIOL, V266, pL23
   Schultz Thomas E, 2005, AANA J, V73, P35
   Schutz N, 2004, BRIT J ANAESTH, V92, P254, DOI 10.1093/bja/aeh049
   Shinagawa K, 2003, AM J RESP CRIT CARE, V168, P959, DOI 10.1164/rccm.200210-1188OC
   Sunyer J, 1999, EUR RESPIR J, V14, P885, DOI 10.1034/j.1399-3003.1999.14d26.x
   TAGUCHI M, 1994, ANESTHESIOLOGY, V81, P628, DOI 10.1097/00000542-199409000-00016
   Takala RSK, 2004, ACTA ANAESTH SCAND, V48, P40, DOI 10.1111/j.1399-6576.2004.00266.x
   Tulic MK, 2003, CHEST, V123, p348S, DOI 10.1378/chest.123.3_suppl.348S
   Wagers S, 2004, J APPL PHYSIOL, V96, P2019, DOI 10.1152/japplphysiol.00924.2003
   Weibel E.R., 1990, MODELS LUNG DIS MICR, V47, P199
   Wiklund CU, 2002, ANESTH ANALG, V95, P1650, DOI 10.1097/00000539-200212000-00032
   Xisto DG, 2005, AM J RESP CRIT CARE, V171, P829, DOI 10.1164/rccm.200408-997OC
NR 39
TC 28
Z9 28
U1 0
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0003-2999
J9 ANESTH ANALG
JI Anesth. Analg.
PD MAR
PY 2007
VL 104
IS 3
BP 631
EP 637
DI 10.1213/01.ane.0000255073.96001.cb
PG 7
WC Anesthesiology
SC Anesthesiology
GA 139KU
UT WOS:000244431500039
PM 17312222
DA 2020-10-30
ER

PT J
AU Fernandes, FC
   Ferreira, HC
   Cagido, VR
   Carvalho, GMC
   Pereira, LS
   Faffe, DS
   Zin, WA
   Rocco, PRM
AF Fernandes, Fatima C.
   Ferreira, Halina C.
   Cagido, Viviane R.
   Carvalho, Giovanna M. C.
   Pereira, Leonel S.
   Faffe, Debora S.
   Zin, Walter A.
   Rocco, Patricia R. M.
TI Effects of dexmedetomidine on respiratory mechanics and control of
   breathing in normal rats
SO RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY
LA English
DT Article
DE mammals; rat; mechanics of breathing; elastance; lung viscoelasticity;
   ventilation; blood gases; pathology; lung histology
ID INCREASING PLASMA-CONCENTRATIONS; AGONIST DEXMEDETOMIDINE; DOGS;
   PRESSURE; HUMANS; LUNG; VENTILATION; TRACHEAL; RABBITS; OUTPUT
AB Dexmedetomidine is a highly selective and specific alpha(2)-adrenergic agorist, with sedative, analgesic, and sympatholytic activities. The aim of the present study was to define the effects of DMED in respiratory mechanics in normal rats. In addition, lung morphometry was studied to determine whether the physiological changes reflected underlying morphological changes defining the sites of action of dexmedetomidine. Arterial blood gases were also determined. Twelve adult Wistar rats were randomly assigned to two groups of six animals each: PENTO and DMED. In PENTO group animals were sedated (diazepam, 5 mg, i.p.) and anaesthetised with pentobarbital sodium (20 mg kg(-1) i.p.). The rats of the DMED group received dexmedetomidine (250 mu g kg(-1) i.p. followed by intravenous infusion of 0.5 mu g kg(-1) h(-1)). In spontaneously breathing rats, minute ventilation, respiratory frequency, and neuromuscular inspiratory drive were lower in dexmedetomidine group, which also presented hypercapnia, whereas tidal volume, inspiratory, expiratory, and total respiratory cycle times were higher in dexmedetomidine group compared to the PENTO group. During mechanical ventilation, respiratory mechanical parameters were similar in both groups. These findings were supported by the absence of histological changes. In conclusion, under the conditions studied, dexmedetomidine did not change respiratory mechanical parameters and lung histology, but induced ventilatory depression. (c) 2006 Elsevier B.V. All rights reserved.
C1 Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Biofis Carlos Chagas Filho, Lab Pulm Invest, BR-21949900 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Fac Med, Dept Surg, BR-21949900 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Physiol Resp Lab, Inst Biofis Carlos Chagas Filho, BR-21949900 Rio De Janeiro, Brazil.
RP Rocco, PRM (corresponding author), Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Biofis Carlos Chagas Filho, Lab Pulm Invest, Ilha Fundao, BR-21949900 Rio De Janeiro, Brazil.
EM prmrocco@biof.ufrj.br
RI Zin, Walter/H-8220-2013
OI Zin, Walter/0000-0001-8226-9123
CR ANDERSON S, 1984, J MOL GRAPHICS, V2, P83, DOI 10.1016/0263-7855(84)80060-0
   Angst MS, 2004, ANESTHESIOLOGY, V101, P744, DOI 10.1097/00000542-200409000-00024
   BATES JHT, 1988, J APPL PHYSIOL, V65, P408
   BAYDUR A, 1982, AM REV RESPIR DIS, V126, P788
   BELLEVILLE JP, 1992, ANESTHESIOLOGY, V77, P1125, DOI 10.1097/00000542-199212000-00013
   BLOOR BC, 1992, J PHARMACOL EXP THER, V263, P690
   Bol CJJG, 1997, J PHARMACOL EXP THER, V283, P1051
   CALDEIRA MPR, 1988, RESP PHYSIOL, V73, P43, DOI 10.1016/0034-5687(88)90126-0
   Correa FCF, 2001, J APPL PHYSIOL, V91, P803
   DOZE VA, 1989, ANESTHESIOLOGY, V71, P75, DOI 10.1097/00000542-198907000-00014
   Ebert TJ, 2000, ANESTHESIOLOGY, V93, P382, DOI 10.1097/00000542-200008000-00016
   Groeben H, 2004, ANESTHESIOLOGY, V100, P359, DOI 10.1097/00000542-200402000-00026
   GRUNDSTROM N, 1985, ACTA PHYSIOL SCAND, V125, P513, DOI 10.1111/j.1748-1716.1985.tb07749.x
   Guo TZ, 1998, ANESTHESIOLOGY, V88, P1634, DOI 10.1097/00000542-199806000-00028
   Hall JE, 2000, ANESTH ANALG, V90, P699, DOI 10.1097/00000539-200003000-00035
   Hsu YW, 2004, ANESTHESIOLOGY, V101, P1066, DOI 10.1097/00000542-200411000-00005
   KNEUSSL MP, 1978, J APPL PHYSIOL, V45, P307
   MANDERS WT, 1976, CIRC RES, V39, P512, DOI 10.1161/01.RES.39.4.512
   MILICEMILI J, 1976, CHEST, V70, P131, DOI 10.1378/chest.70.1.131
   MORTOLA JP, 1983, J APPL PHYSIOL, V55, P250
   NAGASE T, 1992, J APPL PHYSIOL, V73, P1900
   NGUYEN D, 1992, ANESTHESIOLOGY, V76, P573, DOI 10.1097/00000542-199204000-00014
   Nishida T, 2002, INTENS CARE MED, V28, P969, DOI 10.1007/s00134-002-1338-y
   Ramsay MAE, 2004, ANESTHESIOLOGY, V101, P787
   Reta GS, 2000, BRIT J ANAESTH, V84, P372
   Rocco PRM, 1997, RESP PHYSIOL, V110, P9, DOI 10.1016/S0034-5687(97)00067-4
   SAKAE RS, 1994, AM J PHYSIOL, V266, pL23
   SALMENPERA MT, 1994, ANESTHESIOLOGY, V80, P837, DOI 10.1097/00000542-199404000-00017
   SIMILOWSKI T, 1989, J APPL PHYSIOL, V67, P2219
   Venn RM, 2003, INTENS CARE MED, V29, P201, DOI 10.1007/s00134-002-1579-9
   Weibel E.R., 1990, MODELS LUNG DIS MICR, V47, P199
   WHITELAW WA, 1975, RESP PHYSIOL, V23, P181, DOI 10.1016/0034-5687(75)90059-6
   YAMADA KA, 1983, J PHARMACOL EXP THER, V226, P349
   ZORNOW MH, 1992, ANESTH ANALG, V75, P232
   ZORNOW MH, 1991, NEUROPHARMACOLOGY, V30, P1065, DOI 10.1016/0028-3908(91)90135-X
NR 35
TC 9
Z9 9
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1569-9048
EI 1878-1519
J9 RESP PHYSIOL NEUROBI
JI Respir. Physiol. Neuro.
PD DEC
PY 2006
VL 154
IS 3
BP 342
EP 350
DI 10.1016/j.resp.2006.02.002
PG 9
WC Physiology; Respiratory System
SC Physiology; Respiratory System
GA 118NZ
UT WOS:000242950300003
PM 16527548
DA 2020-10-30
ER

PT J
AU Xisto, DG
   Farias, LL
   Ferreira, HC
   Picanco, MR
   Amitrano, D
   Silva, LRLE
   Negri, EM
   Mauad, T
   Carnielli, D
   Silva, LFF
   Capelozzi, VL
   Faffe, DS
   Zin, WA
   Rocco, PRM
AF Xisto, DG
   Farias, LL
   Ferreira, HC
   Picanco, MR
   Amitrano, D
   Silva, LRLE
   Negri, EM
   Mauad, T
   Carnielli, D
   Silva, LFF
   Capelozzi, VL
   Faffe, DS
   Zin, WA
   Rocco, PRM
TI Lung parenchyma remodeling in a murine model of chronic allergic
   inflammation
SO AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
LA English
DT Article
DE actin; collagen; remodeling; tissue mechanics
ID DENDRITIC CELLS; SMALL AIRWAYS; ASTHMATIC SUBJECTS; INDUCED
   CONSTRICTION; TISSUE EOSINOPHILIA; PULMONARY-DISEASE; NOCTURNAL ASTHMA;
   ALVEOLAR TISSUE; ATOPIC ASTHMA; FIBER NETWORK
AB This study tested the hypotheses that chronic allergic inflammation induces not only bronchial but also lung parenchyma remodeling, and that these histologic changes are associated with concurrent changes in respiratory mechanics. For this purpose, airway and lung parenchyma remodeling were evaluated by quantitative analysis of Collagen and elastin, immunohistochemistry (smooth-muscle actin expression, eosinophil, and dendritic cell densities), and electron microscopy. In vivo (airway resistance, viscoelastic pressure, and static elastance) and in vitro (tissue elastance, resistance, and hysteresivity) respiratory mechanics were also analyzed. BALB/c mice were sensitized with ovalbumin and exposed to repeated ovalbumin challenges. A marked eosinophilic infiltration was seen in lung parenchyma and in large and distal airways. Neutrophils, lymphocytes, and dendritic cells also infiltrated the lungs. There was subepithelial fibrosis, myocyte hypertrophy and hyperplasia, elastic fiber fragmentation, and increased numbers of myofibroblasts in airways and lung parenchyma. Collagen fiber content was increased in the alveolar walls. The volume proportion of smooth muscle-specific actin was augmented in distal airways and alveolar duct walls. Airway resistance, viscoelastic pressure, static elastance, and tissue elastance and resistance were significantly increased. In conclusion, prolonged allergen exposure induced remodeling not only of the airway wall but also of the lung parenchyma, leading to in vivo and in vitro mechanical changes.
C1 Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, CCS, Lab Invest Pulm,Ilha Fdn, BR-21949900 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Inst Thorac Dis, Clementino Fraga Filho Univ Hosp, Rio De Janeiro, Brazil.
   Univ Sao Paulo, Lab Cellular Biol, Sao Paulo, Brazil.
   Univ Sao Paulo, Dept Pathol, Sao Paulo, Brazil.
RP Rocco, PRM (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, CCS, Lab Invest Pulm,Ilha Fdn, BR-21949900 Rio De Janeiro, Brazil.
EM prmrocco@biof.ufrj.br
RI Lapa e Silva, Jose R./AAS-4793-2020; Capelozzi, Vera Luiza/C-6363-2013;
   Silva, Luiz/D-2760-2012; Mauad, Thais/G-1254-2012; Negri, Eva Vanna
   Lorenza/AAC-5698-2019; Zin, Walter/H-8220-2013; CAPELOZZI, VERA
   LUIZA/N-1737-2019
OI Lapa e Silva, Jose R./0000-0003-3116-0253; Silva,
   Luiz/0000-0002-0181-6357; Mauad, Thais/0000-0002-3354-1466; Negri, Eva
   Vanna Lorenza/0000-0001-9712-8526; Zin, Walter/0000-0001-8226-9123;
   CAPELOZZI, VERA LUIZA/0000-0001-9732-5853; delmonte,
   samuel/0000-0002-3289-4577
CR Alam R, 2004, J ALLERGY CLIN IMMUN, V113, P38, DOI 10.1016/j.jaci.2003.10.054
   Albertine KH, 2002, AM J PHYSIOL-LUNG C, V283, pL219, DOI 10.1152/ajplung.00324.2001
   Arantes-Costa FM, 2002, EUR RESPIR J, V19, P1008, DOI 10.1183/09031936.02.00232402
   BATES JHT, 1985, J APPL PHYSIOL, V58, P1840
   BELLINI A, 1993, CHEST, V103, P997, DOI 10.1378/chest.103.4.997
   Blyth DI, 1996, AM J RESP CELL MOL, V14, P425, DOI 10.1165/ajrcmb.14.5.8624247
   Bousquet J, 2000, AM J RESP CRIT CARE, V161, P1720, DOI 10.1164/ajrccm.161.5.9903102
   Bousquet J, 1996, AM J RESP CRIT CARE, V153, P1648, DOI 10.1164/ajrccm.153.5.8630616
   BROWN PJ, 1984, THORAX, V39, P131, DOI 10.1136/thx.39.2.131
   Burastero SE, 1999, J ALLERGY CLIN IMMUN, V103, P1136, DOI 10.1016/S0091-6749(99)70189-2
   Busse W, 1999, AM J RESP CRIT CARE, V160, P1035, DOI 10.1164/ajrccm.160.3.9902064
   Carroll N, 1997, EUR RESPIR J, V10, P292, DOI 10.1183/09031936.97.10020292
   CARROLL N, 1993, AM REV RESPIR DIS, V147, P405, DOI 10.1164/ajrccm/147.2.405
   Carroll NG, 2000, AM J RESP CRIT CARE, V161, P244, DOI 10.1164/ajrccm.161.1.9805005
   Cheng XM, 2003, IMMUNOL LETT, V89, P31, DOI 10.1016/S0165-2478(03)00107-X
   Dolhnikoff M, 1999, AM J RESP CRIT CARE, V160, P1750, DOI 10.1164/ajrccm.160.5.9812040
   Dolhnikoff M, 1998, AM J RESP CRIT CARE, V158, P1607, DOI 10.1164/ajrccm.158.5.9801068
   Duvernelle C, 2003, PULM PHARMACOL THER, V16, P181, DOI 10.1016/S1094-5539(03)00051-8
   Faffe DS, 2001, J APPL PHYSIOL, V90, P1400
   Flood-Page P, 2003, J CLIN INVEST, V112, P1029, DOI 10.1172/JCI200317974
   FREDBERG JJ, 1989, J APPL PHYSIOL, V67, P2408
   Hamid Q, 1997, J ALLERGY CLIN IMMUN, V100, P44, DOI 10.1016/S0091-6749(97)70193-3
   Harris N, 1997, J EXP MED, V185, P177, DOI 10.1084/jem.185.1.177
   HESSEL EM, 1995, J APPL PHYSIOL, V79, P1711
   Hirst SJ, 1996, EUR RESPIR J, V9, P808, DOI 10.1183/09031936.96.09040808
   Homer RJ, 2000, CLIN CHEST MED, V21, P331, DOI 10.1016/S0272-5231(05)70270-7
   INGENITO EP, 1993, J APPL PHYSIOL, V75, P2541
   JAMES AL, 1989, AM REV RESPIR DIS, V139, P242, DOI 10.1164/ajrccm/139.1.242
   Kaminsky DA, 2000, AM J RESP CRIT CARE, V162, P179, DOI 10.1164/ajrccm.162.1.9806079
   Kapanci Y., 1997, LUNG SCI FDN, P697
   Komai M, 2003, BRIT J PHARMACOL, V138, P912, DOI 10.1038/sj.bjp.0705105
   Kraft M, 1999, AM J RESP CRIT CARE, V159, P228, DOI 10.1164/ajrccm.159.1.9804033
   Kraft M, 2001, AM J RESP CRIT CARE, V163, P1551, DOI 10.1164/ajrccm.163.7.2008013
   Kraft M, 1996, AM J RESP CRIT CARE, V154, P1505, DOI 10.1164/ajrccm.154.5.8912772
   KUWANO K, 1993, AM REV RESPIR DIS, V148, P1220, DOI 10.1164/ajrccm/148.5.1220
   Lagranderie M, 2003, IMMUNOLOGY, V108, P352, DOI 10.1046/j.1365-2567.2003.01609.x
   Lambrecht BN, 2003, NAT REV IMMUNOL, V3, P994, DOI 10.1038/nri1249
   LeickMaldonado EA, 1997, J SUBMICR CYTOL PATH, V29, P427
   LESLIE KO, 1992, CELL MOTIL CYTOSKEL, V22, P92, DOI 10.1002/cm.970220203
   Lima C., 2002, Clinical and Experimental Allergy, V32, P1659, DOI 10.1046/j.1365-2222.2002.01506.x
   Lloyd CM, 2001, ADV IMMUNOL, V77, P263, DOI 10.1016/S0065-2776(01)77019-8
   Lopez-Aguilar J, 1998, RESP PHYSIOL, V113, P239, DOI 10.1016/S0034-5687(98)00054-1
   LUDWIG MS, 1989, J APPL PHYSIOL, V67, P1220
   Mcmillan SJ, 2004, CLIN EXP ALLERGY, V34, P497, DOI 10.1111/j.1365-2222.2004.01895.x
   Moller GM, 1996, CLIN EXP ALLERGY, V26, P517, DOI 10.1046/j.1365-2222.1996.d01-337.x
   Montes GS, 1996, CELL BIOL INT, V20, P15, DOI 10.1006/cbir.1996.0004
   NAGASE T, 1994, AM J RESP CRIT CARE, V150, P218, DOI 10.1164/ajrccm.150.1.8025752
   Nagase T, 1998, CAN J PHYSIOL PHARM, V76, P176
   NAGASE T, 1992, J APPL PHYSIOL, V73, P1900
   NOGUCHI H, 1992, AM J PATHOL, V140, P521
   Palmans E, 2000, AM J RESP CRIT CARE, V161, P627, DOI 10.1164/ajrccm.161.2.9902094
   Phipps S, 2002, J IMMUNOL, V169, P4604, DOI 10.4049/jimmunol.169.8.4604
   Rocco PRM, 2003, AM J RESP CRIT CARE, V168, P677, DOI 10.1164/rccm.200302-256OC
   Rocco PRM, 2001, AM J RESP CRIT CARE, V164, P1067, DOI 10.1164/ajrccm.164.6.2007062
   ROCCO PRM, 2003, EUR RESPIR J, V22, P3044
   ROCHE WR, 1989, LANCET, V1, P520
   SAKAE RS, 1994, AM J PHYSIOL, V266, pL23
   Schlick W, 1993, Monaldi Arch Chest Dis, V48, P237
   SEKIZAWA K, 1986, AM REV RESPIR DIS, V133, P593
   Shinagawa K, 2003, AM J RESP CRIT CARE, V168, P959, DOI 10.1164/rccm.200210-1188OC
   Tulic MK, 2003, CHEST, V123, p348S, DOI 10.1378/chest.123.3_suppl.348S
   Tulic MK, 2001, RESP RES, V2, P333, DOI 10.1186/rr83
   Upham JW, 2003, PHARMACOL THERAPEUT, V100, P75, DOI 10.1016/S0163-7258(03)00094-9
   Vignola AM, 2003, CHEST, V123, p417S, DOI 10.1378/chest.123.3_suppl.417S
   Wagers S, 2004, J APPL PHYSIOL, V96, P2019, DOI 10.1152/japplphysiol.00924.2003
   Wagner EM, 1998, AM J RESP CRIT CARE, V157, P447, DOI 10.1164/ajrccm.157.2.9611043
   WAGNER EM, 1990, AM REV RESPIR DIS, V141, P584, DOI 10.1164/ajrccm/141.3.584
   Weibel E.R., 1990, MODELS LUNG DIS MICR, V47, P199
   Weigert C, 1898, Z ALLG PATHOL, V9, P289
   Wenzel SE, 1997, AM J RESP CRIT CARE, V156, P737, DOI 10.1164/ajrccm.156.3.9610046
   Williams TJ, 2004, J CLIN INVEST, V113, P507, DOI 10.1172/JCI200421073
   WILSON JW, 1993, AM REV RESPIR DIS, V148, P806, DOI 10.1164/ajrccm/148.3.806
   WONG DTW, 1993, AM J PATHOL, V143, P130
   XISTO DG, 2004, AM J RESP CRIT CARE, V169, pA295
   YANAI M, 1992, J APPL PHYSIOL, V72, P1016
   Yiamouyiannis CA, 1999, AM J PATHOL, V154, P1911, DOI 10.1016/S0002-9440(10)65449-1
   YING S, 2002, ACI INT, V14, P64
   Yuan HC, 1997, J APPL PHYSIOL, V83, P1420
NR 78
TC 73
Z9 74
U1 0
U2 5
PU AMER THORACIC SOC
PI NEW YORK
PA 25 BROADWAY, 18 FL, NEW YORK, NY 10004 USA
SN 1073-449X
EI 1535-4970
J9 AM J RESP CRIT CARE
JI Am. J. Respir. Crit. Care Med.
PD APR 15
PY 2005
VL 171
IS 8
BP 829
EP 837
DI 10.1164/rccm.200408-997OC
PG 9
WC Critical Care Medicine; Respiratory System
SC General & Internal Medicine; Respiratory System
GA 916VP
UT WOS:000228414800006
PM 15657464
DA 2020-10-30
ER

PT J
AU Rocco, PRM
   Facchinetti, LD
   Ferreira, HC
   Negri, EM
   Capelozzi, VL
   Faffe, DS
   Zin, WA
AF Rocco, PRM
   Facchinetti, LD
   Ferreira, HC
   Negri, EM
   Capelozzi, VL
   Faffe, DS
   Zin, WA
TI Time course of respiratory mechanics and pulmonary structural
   remodelling in acute lung injury
SO RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY
LA English
DT Article
DE mechanics of breathing; elastance; lung viscoelasticity; hysteresivity;
   extracellular matrix; collagen; elastin; mammals; rat; pathology; lung
   histopathology
ID DISTRESS-SYNDROME; EXTRACELLULAR-MATRIX; FLOW INTERRUPTION; TISSUE
   MECHANICS; EARLY PHASE; FIBROSIS; PROCOLLAGEN; RATS; FIBROPROLIFERATION;
   PARENCHYMA
AB The aim of this study was to evaluate the time course of in vivo and in vitro respiratory mechanics and examine whether these parameters could reflect the temporal changes in lung parenchyma remodelling in paraquat (PQ)-induced lung injury. Measurements were done 1, 3 and 8 weeks after the intraperitoneal (i.p.) injection of saline (control) or paraquat (7 mg kg(-1)) in rats. Airway and tissue resistances increased from control in PQ1 and PQ3 and returned to control values in PQ8, in accordance with the magnitude of bronchoconstriction. Viscoelastic/inhomogeneous pressure, tissue elastance, the number of polymorphonuclear cells, and collagen fibre content in lung parenchyma increased in PQ1 and remained elevated in PQ3 and PQ8. Static elastance increased in PQ1, returned to control values after 3 weeks, and was correlated with the volume fraction of collapsed alveoli. In conclusion, there is a restoration of normal alveolar-capillary lung units with a gradual improvement in airway and tissue resistances and static elastance. However, the on-going fibrotic process kept elevated tissue elastance and viscoelastic/inhomogeneous pressure. (C) 2004 Elsevier B.V. All rights reserved.
C1 Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Pulm Invest, Ilha Fdn, BR-21949900 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Physiol Resp Lab, Ilha Fdn, BR-21949900 Rio De Janeiro, Brazil.
   Hosp AC Camargo Fund Antonio Prudente, Dept Thorac Med, Sao Paulo, Brazil.
   Univ Sao Paulo, Fac Med, Dept Pathol, BR-05508 Sao Paulo, Brazil.
RP Rocco, PRM (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Pulm Invest, Ilha Fdn, BR-21949900 Rio De Janeiro, Brazil.
EM prmrocco@biof.ufrj.br
RI CAPELOZZI, VERA LUIZA/N-1737-2019; Negri, Elnara M/F-3643-2019;
   Capelozzi, Vera Luiza/C-6363-2013; Zin, Walter/H-8220-2013
OI CAPELOZZI, VERA LUIZA/0000-0001-9732-5853; Negri, Elnara
   M/0000-0002-6428-6066; Zin, Walter/0000-0001-8226-9123; delmonte,
   samuel/0000-0002-3289-4577
CR BATES JHT, 1987, MED BIOL ENG COMPUT, V25, P136, DOI 10.1007/BF02442841
   BATES JHT, 1988, J APPL PHYSIOL, V64, P2204
   BAYDUR A, 1982, AM REV RESPIR DIS, V126, P788
   Chesnutt AN, 1997, AM J RESP CRIT CARE, V156, P840, DOI 10.1164/ajrccm.156.3.9701124
   DANGELO E, 1989, J APPL PHYSIOL, V67, P2556
   DELAVAL PM, 1985, CRIT CARE MED, V13, P1056, DOI 10.1097/00003246-198512000-00015
   Ebihara T, 2000, AM J RESP CRIT CARE, V162, P1569, DOI 10.1164/ajrccm.162.4.9912011
   Faffe DS, 2001, J APPL PHYSIOL, V90, P1400
   FREDBERG JJ, 1989, J APPL PHYSIOL, V67, P2408
   Fullmer H M, 1974, J Oral Pathol, V3, P291, DOI 10.1111/j.1600-0714.1974.tb01724.x
   GREGORY TJ, 1991, J CLIN INVEST, V88, P1976, DOI 10.1172/JCI115523
   GROSSMAN RF, 1980, J APPL PHYSIOL, V48, P1045
   Hoff CR, 1999, CONNECT TISSUE RES, V40, P145, DOI 10.3109/03008209909029110
   KOCHI T, 1988, J APPL PHYSIOL, V64, P441
   Liebler JM, 1998, THORAX, V53, P823, DOI 10.1136/thx.53.10.823
   Lopez-Aguilar J, 1998, RESP PHYSIOL, V113, P239, DOI 10.1016/S0034-5687(98)00054-1
   Marshall RP, 2000, AM J RESP CRIT CARE, V162, P1783, DOI 10.1164/ajrccm.162.5.2001061
   Meduri GU, 1998, AM J RESP CRIT CARE, V158, P1432
   MIJAILOVICH SM, 1993, J APPL PHYSIOL, V74, P665
   Montes GS, 1996, CELL BIOL INT, V20, P15, DOI 10.1006/cbir.1996.0004
   MORTOLA JP, 1983, J APPL PHYSIOL, V55, P250
   Nagase T, 1996, J APPL PHYSIOL, V80, P583
   Pugin J, 1999, CRIT CARE MED, V27, P304, DOI 10.1097/00003246-199902000-00036
   RAGHOW R, 1985, J CLIN INVEST, V76, P1733, DOI 10.1172/JCI112163
   RAGHU G, 1985, AM REV RESPIR DIS, V131, P281, DOI 10.1164/ajrccm/138.3.703
   Rocco PRM, 2003, AM J RESP CRIT CARE, V168, P677, DOI 10.1164/rccm.200302-256OC
   Rocco PRM, 2001, AM J RESP CRIT CARE, V164, P1067, DOI 10.1164/ajrccm.164.6.2007062
   SAKAE RS, 1994, AM J PHYSIOL-LUNG C, V266, P23
   SALDIVA PHN, 1992, J APPL PHYSIOL, V72, P302
   SIMILOWSKI T, 1989, J APPL PHYSIOL, V67, P2219
   SMITH P, 1974, J PATHOL, V114, P57, DOI 10.1002/path.1711140202
   WEIBEL E, 1990, MORPHOMETRY STEREOLO
   Weigert C, 1898, Z ALLG PATHOL, V9, P289
   Yuan HC, 2000, J APPL PHYSIOL, V89, P3
   Yuan HC, 1997, J APPL PHYSIOL, V83, P1420
NR 35
TC 19
Z9 21
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1569-9048
J9 RESP PHYSIOL NEUROBI
JI Respir. Physiol. Neuro.
PD OCT 12
PY 2004
VL 143
IS 1
BP 49
EP 61
DI 10.1016/j.resp.2004.06.017
PG 13
WC Physiology; Respiratory System
SC Physiology; Respiratory System
GA 866OU
UT WOS:000224783600005
PM 15477172
DA 2020-10-30
ER

PT J
AU Rocco, PRM
   Momesso, DP
   Figueira, RC
   Ferreira, HC
   Cadete, RA
   Legora-Machado, A
   Koatz, VLG
   Lima, LM
   Barreiro, EJ
   Zin, WA
AF Rocco, PRM
   Momesso, DP
   Figueira, RC
   Ferreira, HC
   Cadete, RA
   Legora-Machado, A
   Koatz, VLG
   Lima, LM
   Barreiro, EJ
   Zin, WA
TI Therapeutic potential of a new phosphodiesterase inhibitor in acute lung
   injury
SO EUROPEAN RESPIRATORY JOURNAL
LA English
DT Article
DE inflammation; lung morphometry; phosphodiesterasc inhibitor; respiratory
   mechanics
ID ANTIINFLAMMATORY ACTIVITY; FIBROBLAST CHEMOTAXIS; TISSUE MECHANICS;
   DOUBLE-BLIND; GUINEA-PIGS; RAT MODEL; MICE; PENTOXIFYLLINE; ROLIPRAM;
   INFLAMMATION
AB The effects of LASSBio596, a phosphodiesterase type-4 and -5 inhibitor, were tested in Escherichia coli lipopolysaccharide (LPS)-induced acute lung injury.
   Twenty-four BALB/c mice were randomly divided into four groups. In the control group, saline (0.05 mL) was injected intratracheally (i.t.). The LPS group received LPS (10 mug i.t., 0.05 mL). In the LASSBio596 groups, LASSBio596 (10 mg(.)kg(-1), 0.2 mL) was injected intra peritoneally 1 h before or 6 h after LPS administration. After 24 h, in vivo (lung resistive and viscoelastic pressures, and static and dynamic elastances) and in vitro (tissue resistance, elastance and hysteresivity) pulmonary mechanics, lung morphometry and collagenous fibre content were computed. Neutrophils and tumour necrosis factor (TNF)-alpha levels were evaluated in the bronchoalveolar lavage fluid.
   LASSBio596 prevented the changes in lung mechanics, and inhibited neutrophilic recruitment, TNF-alpha release, bronchoconstriction, alveolar collapse and the increment of collagen fibre content induced by LPS, independently of the moment of injection.
   In conclusion, LASSBio596 modulated the lung inflammatory process and had the potential to block fibroproliferation. Thus, agents that inhibit phosphodiesterase 4 and 5 simultaneously may be a useful adjunct therapy for acute lung injury.
C1 Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Physiol Resp Lab, BR-21941 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Dept Med Biochem, Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Lab Avaliacao & Sintese Substancias Bioativas, Rio De Janeiro, Brazil.
RP Zin, WA (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, CCS, Lab Fisiol Resp Ilha Fundao, BR-21949900 Rio De Janeiro, Brazil.
RI Barreiro, Eliezer J/B-1131-2011; Zin, Walter/H-8220-2013
OI Zin, Walter/0000-0001-8226-9123; Moreira Lima, Lidia/0000-0002-8625-6351
CR AGOSTONI E, 1964, HANDBOOK PHYSIOLOG 3, V1, P387
   Asti C, 2000, PULM PHARMACOL THER, V13, P61, DOI 10.1006/pupt.2000.0231
   BATES JHT, 1988, J APPL PHYSIOL, V64, P2204
   Corbel M, 2002, J PHARMACOL EXP THER, V301, P258, DOI 10.1124/jpet.301.1.258
   Creamer KM, 2001, CHEST, V119, P1893, DOI 10.1378/chest.119.6.1893
   de Moraes VLG, 1998, BRIT J PHARMACOL, V123, P631
   Essayan DM, 2001, J ALLERGY CLIN IMMUN, V108, P671, DOI 10.1067/mai.2001.119555
   Faffe DS, 2000, EUR RESPIR J, V15, P85, DOI 10.1183/09031936.00.15108500
   Faffe DS, 2001, J APPL PHYSIOL, V90, P1400
   FREDBERG JJ, 1989, J APPL PHYSIOL, V67, P2408
   Hafner D, 2000, AM J RESP CRIT CARE, V161, P1495
   Holzmann A, 2001, INTENS CARE MED, V27, P251, DOI 10.1007/s001340000774
   HOWELL RE, 1995, J PHARMACOL EXP THER, V275, P703
   Ichinose F, 2001, CRIT CARE MED, V29, P1000, DOI 10.1097/00003246-200105000-00024
   Ichinose F, 1998, ANESTHESIOLOGY, V88, P410, DOI 10.1097/00000542-199802000-00020
   KAMBAYASHI T, 1995, J IMMUNOL, V155, P4909
   Kohyama T, 2002, AM J RESP CELL MOL, V26, P694, DOI 10.1165/ajrcmb.26.6.4743
   Kohyama T, 2001, CHEST, V120, p14S, DOI 10.1378/chest.120.1_suppl.S14
   Lauterbach R, 1999, CRIT CARE MED, V27, P807, DOI 10.1097/00003246-199904000-00042
   Lima LM, 2002, BIOORGAN MED CHEM, V10, P3067, DOI 10.1016/S0968-0896(02)00152-9
   Lopez-Aguilar J, 1998, RESP PHYSIOL, V113, P239, DOI 10.1016/S0034-5687(98)00054-1
   Miotla JM, 1998, AM J RESP CELL MOL, V18, P411, DOI 10.1165/ajrcmb.18.3.2913
   Montes GS, 1996, CELL BIOL INT, V20, P15, DOI 10.1006/cbir.1996.0004
   MORTOLA JP, 1983, J APPL PHYSIOL, V55, P250
   Nagase T, 1996, J APPL PHYSIOL, V80, P583
   RICE GC, 1994, P NATL ACAD SCI USA, V91, P3857, DOI 10.1073/pnas.91.9.3857
   Rocco PRM, 2001, AM J RESP CRIT CARE, V164, P1067, DOI 10.1164/ajrccm.164.6.2007062
   SAKAE RS, 1994, AM J PHYSIOL, V2669, P223
   SEKUT L, 1995, CLIN EXP IMMUNOL, V100, P126
   SIMILOWSKI T, 1989, J APPL PHYSIOL, V67, P2219
   Spond J, 2001, PULM PHARMACOL THER, V14, P157, DOI 10.1006/pupt.2001.0291
   Staubach KH, 1998, ARCH SURG-CHICAGO, V133, P94, DOI 10.1001/archsurg.133.1.94
   Steinhorn RH, 2000, CRIT CARE MED, V28, P490, DOI 10.1097/00003246-200002000-00034
   Toward TJ, 2002, J PHARMACOL EXP THER, V302, P814, DOI 10.1124/jpet.102.033951
   TURNER CR, 1993, CIRC SHOCK, V39, P237
   Weibel E.R., 1990, MODELS LUNG DIS MICR, V47, P199
   Wiedemann HP, 2002, CRIT CARE MED, V30, P1
   Yuan HC, 1997, J APPL PHYSIOL, V83, P1420
   ZABEL P, 1989, LANCET, V2, P1474
NR 39
TC 33
Z9 33
U1 0
U2 0
PU EUROPEAN RESPIRATORY SOC JOURNALS LTD
PI SHEFFIELD
PA 146 WEST ST, STE 2.4, HUTTONS BLDG, SHEFFIELD S1 4ES, ENGLAND
SN 0903-1936
J9 EUR RESPIR J
JI Eur. Resp. J.
PD JUL
PY 2003
VL 22
IS 1
BP 20
EP 27
DI 10.1183/09031936.03.00108603
PG 8
WC Respiratory System
SC Respiratory System
GA 701NV
UT WOS:000184174400006
PM 12882446
OA Bronze
DA 2020-10-30
ER

PT J
AU Guinsburg, R
   Almeida, MFB
   Zagari, MCF
   Latorre, MRDO
   Santos, AMN
   Daniel, AS
   Ferreira, H
   Kopelman, B
AF Guinsburg, R
   Almeida, MFB
   Zagari, MCF
   Latorre, MRDO
   Santos, AMN
   Daniel, AS
   Ferreira, H
   Kopelman, B
TI Contributing factors to analgesic prescription in mechanically
   ventilated newborn infants
SO PEDIATRIC RESEARCH
LA English
DT Meeting Abstract
C1 Univ Fed Sao Paulo, Div Neonatol, Sao Paulo, Brazil.
   Univ Sao Paulo, Sch Publ Hlth, Sao Paulo, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU INT PEDIATRIC RESEARCH FOUNDATION, INC
PI BALTIMORE
PA 351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436 USA
SN 0031-3998
J9 PEDIATR RES
JI Pediatr. Res.
PD MAR
PY 2000
VL 47
IS 3
MA 11
BP 424
EP 424
PG 1
WC Pediatrics
SC Pediatrics
GA 287HH
UT WOS:000085500100034
DA 2020-10-30
ER

PT J
AU Guinsburg, R
   Almeida, MFB
   Zagari, MCF
   Latorre, MDDO
   Santos, AMN
   Daniel, AS
   Ferreira, HMGC
   Kopelman, BI
AF Guinsburg, R
   Almeida, MFB
   Zagari, MCF
   Latorre, MDDO
   Santos, AMN
   Daniel, AS
   Ferreira, HMGC
   Kopelman, BI
TI Contributing factors to analgesic prescription in mechanically
   ventilated newborn infants
SO PEDIATRIC RESEARCH
LA English
DT Meeting Abstract
C1 Univ Fed Sao Paulo, Div Neonatol, Sao Paulo, Brazil.
RI Guinsburg, Ruth/F-1984-2013; Latorre, Maria RDO/J-5780-2014
OI Guinsburg, Ruth/0000-0003-1967-9861; Latorre, Maria
   RDO/0000-0002-5189-3457
NR 0
TC 1
Z9 1
U1 0
U2 0
PU INT PEDIATRIC RESEARCH FOUNDATION, INC
PI BALTIMORE
PA 351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436 USA
SN 0031-3998
J9 PEDIATR RES
JI Pediatr. Res.
PD APR
PY 1999
VL 45
IS 4
MA 1172
BP 200A
EP 200A
PN 2
PG 1
WC Pediatrics
SC Pediatrics
GA 182AQ
UT WOS:000079476701173
DA 2020-10-30
ER

EF